相关实验视频

Updated: Sep 14, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.5K

多个基于ctDNA的生物标志物预测了非小细胞肺癌患者选择性RET抑制的益处:前性研究的探索性分析

Chang Lu1, Chong-Rui Xu1, Yi-Chen Zhang1

  • 1Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Biomarker research
|July 23, 2025
PubMed
概括

循环瘤DNA (ctDNA) 的序列分析有效地监测了接受pralsetinib的RET融合阳性非小细胞肺癌 (NSCLC) 患者的治疗反应. 早期ctDNA清除和特定的动态配置文件预测了更好的结果和疾病进展,使及时干预成为可能.

关键词:
循环瘤DNA是循环中的瘤DNA.非小细胞肺癌的非小细胞肺癌.普拉塞西尼布 (pralsetinib) 是一种药物.在RET的基础上,RET是RET.铁氨酸激酶抑制剂 铁氨酸激酶抑制剂

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K